<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00718926</url>
  </required_header>
  <id_info>
    <org_study_id>C244</org_study_id>
    <nct_id>NCT00718926</nct_id>
  </id_info>
  <brief_title>The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients</brief_title>
  <official_title>The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meiji University of Oriental Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kyoto Prefectural University of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Meiji University of Oriental Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dry eye disease is related with oxidative stress at the ocular surface. GSH is one of the key
      factor of protect from oxidative stress. To evaluate thiol status of ocular surface cells by
      monitoring GSH concentration, we can evaluate the severity of dry eye.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The conjunctival cells are collected by impression cytology. Those cells are stained with 100
      mM of monochlorobimane (MCB, M-1381, Molecular Probes, Eugene, OR) and propidium iodide (PI).
      Fluorescent intensity, reflecting the amount of icGSH, was inspected under a confocal laser
      scan microscope. To detect the GSH levels we used a fluorescent MCB probe with excitation and
      emission wavelengths of 405 nm and 410-480 nm, respectively. The cell-permeating MCB probe is
      non-fluorescent but forms a fluorescent adduct with GSH in a reaction catalyzed by
      glutathione-S-transferase.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2008</start_date>
  <completion_date type="Anticipated">March 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Tear amount, tear break up time, and so on are measured clinically. The thiol redox status is measured by staining the membrane.</measure>
    <time_frame>Once a month (totally 2-4 times) at the clinic</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Dry Eye Disease</condition>
  <arm_group>
    <arm_group_label>Sjogren</arm_group_label>
    <description>Sjogren syndrome with dry eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-Sjogren</arm_group_label>
    <description>dry eye without Sjogren syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Short-BUT</arm_group_label>
    <description>Dry eye by shortened tear break up time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>normal patients</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      After application of anethesia eyedrops, nitrocel membrane is put ocular surface. Then,
      removed the membrane. This method is commonly used clinically.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The dry eye patients at the clinic of Kyoto Prefectural University of Medicine hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  dry eye patients

          -  control volunteers

        Exclusion Criteria:

          -  Young (less than 20) patients

          -  The patients who rejected this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jun Yamada, MD, PhD.</last_name>
    <phone>+81-75-251-5663</phone>
    <email>jyamada@koto.kpu-m.ac.jp</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Norihiko Yokoi, MD, PhD.</last_name>
    <phone>+81-75-251-5663</phone>
    <email>nyokoi@koto.kpu-m.ac.jp</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kyoto Prefectural University of Medicine hospital</name>
      <address>
        <city>Kyoto</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shigeru Kinoshita, MD, PhD.</last_name>
      <phone>+81-75-251-5577</phone>
      <email>shigeruk@koto.kpu-m.ac.jp</email>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2008</study_first_submitted>
  <study_first_submitted_qc>July 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2008</study_first_posted>
  <last_update_submitted>July 18, 2008</last_update_submitted>
  <last_update_submitted_qc>July 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2008</last_update_posted>
  <responsible_party>
    <name_title>Jun Yamada MD. PhD.</name_title>
    <organization>Meiji University of Oriental Medicine</organization>
  </responsible_party>
  <keyword>dry eye</keyword>
  <keyword>Thiol redox</keyword>
  <keyword>Oxidative stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

